What are the two issues facing researchers in naturalistic observation?

In order to continue enjoying our site, we ask that you confirm your identity as a human. Thank you very much for your cooperation.

In order to continue enjoying our site, we ask that you confirm your identity as a human. Thank you very much for your cooperation.

1. Meltzer H., Brugha TS. Ethical concerns in carrying out surveys of psychiatric morbidity. In: Helmchen H, Sartorius N, eels. Ethics in Psychiatry. Dordrecht-Heidelberg-London-New York: Springer. 2010; 2010:437–458. [Google Scholar]

2. Emanuel EJ., Miller FG. The ethics of placebo-controlled trials - a middle ground. N Engl J Med. 2001;345:915–919. [PubMed] [Google Scholar]

3. Carpenter WT Jr., Appelbaum PS., Levine RJ. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. Am J Psychiatry. 2003;160:356–362. [PubMed] [Google Scholar]

4. Addington D., Williams R., Lapierre Y., el-Guebaly N. Placebos in clinical trials of psychotropic medication. Can J Psychiatry. 1997;42:6. [PubMed] [Google Scholar]

5. Benkert O., Maier W. The necessity of placebo application in psychotropic drug trials. Pharmacopsychiatry. 1990;23:203–205. [PubMed] [Google Scholar]

6. Baldwin D., Broich K., Fritze J., Kasper S., Westenberg H., Môller HJ. Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci. 2003;253:22–28. [PubMed] [Google Scholar]

7. EMEA . Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Depression. 25:4–2002. [Google Scholar]

8. Fournier JC., DeRubeis RJ., Hollon SD., et al Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47–53. [PMC free article] [PubMed] [Google Scholar]

9. Bauer M. Placeboeffekte bei Arzneimittelprûfungen von Antidepressiva: Interpretation und Bedeutung. Paper presented at: The annual congress of the German Society for Psychiatry, Psychotherapy and Clincal Neuroscience. 2009 November [Google Scholar]

10. Garattini S., Bertelé V. Non-inferiority trials are unethical because they disregard patients' interests. Lancet. 2007;370:1875–1877. [PubMed] [Google Scholar]

11. Helmchen H. Ethische Implikationen placebokontrollierter Prûfungen von Psychopharmaka. Nervenarzt. 2005;76:1319–1329. [PubMed] [Google Scholar]

12. Garattini S., Bertele V., Bassi LL. How can research ethics committees protect patients better?. BMJ. 2003;326:1199–1201. [PMC free article] [PubMed] [Google Scholar]

13. Miller FG., Joffe S. Evaluating the therapeutic misconception. Kennedy Inst Ethics J. 2006;16:353–366. [PubMed] [Google Scholar]

14. Appelbaum PS., Roth LH., Lidz CW. The therapeutic misconception: informed consent in psychiatric research. IntJ Law Psychiatry. 1982;5:319–29. [PubMed] [Google Scholar]

15. Kimmelman J. The therapeutic misconception at 25: treatment, research, and confusion. Hastings Cent Rep. 2007;37:36–42. [PubMed] [Google Scholar]

16. Appelbaum PS., Lidz CW. Re-evaluating the therapeutic misconception: response to Miller and Joffe. Kennedy inst Ethics J. 2008;16:367–373. [PubMed] [Google Scholar]

17. Lidz CW., Appelbaum PS., Grisso T., Renaud M. Therapeutic misconception and the appreciation of risks in clinical trials. Int J Law Psychiatry. 2004;58:1689–1697. [PubMed] [Google Scholar]

18. Empfehlungen des Bundesinstituts fur Arzneimittel und Medizinprodukte und des Paul-Ehrlich-Instituts zur Planung, Durchfûhrung und Auswertung von Anwendungsbeobachtungen vom 7. Jull 2010. Available at: http://bjp.rcpsych.org/cgi/citmgr?gca=bjprcpsych/1 88/6/504. 2010. Accessed 4.11.2010 [Google Scholar]

19. Benson K., Hartz AJ. A comparison of observational studies and randomized, controlled trials. In: Pimple KD, eds. Research Ethics. Aldershot: Ashgate. 2008:213–221. [Google Scholar]

20. Illes J., Borgelt E. Brain imaging. Incidental findings: in practice and in person. Nat Rev Neurol. 2009;5:643–644. [PMC free article] [PubMed] [Google Scholar]

21. Morris Z. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016. [PMC free article] [PubMed] [Google Scholar]

22. Wolf SM., Lawrenz FP., Nelson CA., et al Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36:219–248. [PMC free article] [PubMed] [Google Scholar]

23. Tovino SA. Incidental findings: a common law approach. Account Res. 2008;15:242–261. [PubMed] [Google Scholar]

24. Shaw RL., Senior C., Peel E., Cooke R., Donnelly LS. Ethical issues in neuroimaging health research. J Health Psychol. 2008;13:1051–1059. [PubMed] [Google Scholar]

25. Nuthmann R., Wahl HW. Methodische Aspkte der Erhebungen. In: Lindenberger U, Smith J, Mayer KL), Baltes PB, eds. Die Berliner Altersstudie. 3 ed. Berlin: Akademie Verlag. 2010:59–87. [Google Scholar]

26. Illes J., Chin VN. Bridging philosophical and practical implications of incidental findings in brain research. J Law Med Ethics. 2008;36:298–304. [PMC free article] [PubMed] [Google Scholar]

27. Illes J. Empowering brain science with neuroethics. Lancet. 2010;376:1294–1295. [PubMed] [Google Scholar]

28. Illes J., Kirschen MP., Edwards E., et al Practical approaches to incidental findings in brain imaging research. Neurology. 2008;70:384–390. [PMC free article] [PubMed] [Google Scholar]

29. Went L. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genetics. 1990;27:34–38. [PMC free article] [PubMed] [Google Scholar]

30. Propping P. Genetics - Ethical implications of research, diagnostics and counseling. In: Helmchen H, Sartorius N, eds. Ethics in Psychiatry. DordrechtHeidelberg-London-New York: Springer. 2010:459–485. [Google Scholar]

31. McClelland R. Confidentiality. In: Helmchen H, Sartorius N, eds. Ethics in Psychiatry. Dordrecht-Heidelberg-London-New York: Springer. 2010:161–180. [Google Scholar]

32. Simonsen S. Acceptable risk and the requirement of proportionality in European Biomedical Research Law. What does the requirement that biomedical research shall not involve risks and burdens disproportionate to its potential benefits mean? Jurisprudential doctoral thesis 2009. Norwegian University of Science and Technology (NTNU), Trondheim. [Google Scholar]

33. Rajczi A. Making risk-benefit assessments of medical research protocols. J Law Med Ethics. 2004;32:338–348. [PubMed] [Google Scholar]

34. Wendler D., Miller FG. Assessing research risks systematically: the net risks test. J Med Ethics. 2007;33:481–486. [PMC free article] [PubMed] [Google Scholar]

35. Wendler D., Krohmal B., Eanuel EJ., Grady C., ESPRIT Group. Why patients continue to participate in clinical research. Arch Intern Med. 2008;168:1294–1299. [PubMed] [Google Scholar]

36. Sofaer N., Jafarey A., Lei RP., Zhang X., Wikler D. Unconditional compensation: reducing the costs of disagreement about compensation for research subjects. East Mediterr Health J. 2007;13:6–16. [PubMed] [Google Scholar]

37. Connell CM., Shaw B., Holmes SB., Forster NL. Caregivers' attitudes toward their family members' participation in Alzheimer disease research: implications for recruitment and retention. Alzheimer Dis Assoc Disord. 2001;15:137–145. [PubMed] [Google Scholar]

38. Mastwyk M., Ritchie CW., LoGiudice D., Sullivan KA., Macfarlane S. Carers' impressions of participation in Alzheimer's disease clinical trials: what are their hopes? And is it worth it?. International Psychogeriatrics. 2002;14:39–45. [PubMed] [Google Scholar]

39. Helmchen H. Clinical research in the mentally ill. Ethical considerations. In: Thiele F, Fegert JM, Stock G, eds. Clinical Research in Minors and the Mentally III. Bad Neuenahr-Âhrweiler: Europâische Akademie zur Erforschung von der Folgen wissenschaftlich-technischer Entwicklungen. 2008:7–32. [Google Scholar]

40. Helmchen H. Ethical guidelines in psychiatric research. Eur Arch Psychiatry Clin Neurosci. 2010;260:142–146. [PubMed] [Google Scholar]

41. Helmchen H. Biomedizinische Forschung mit einwilligungsunfâhigen Erwachsenen. In: Taupitz J, ed. Das Menschenrechtsubereinkommen zur Biomedizin des Europarates - taugiiches Vorbiid fur eine weitweit geitende Regeiung? Berlin - Heidelberg - New York: Springer. 2002:83–115. [Google Scholar]

42. Wendler D., Jenkins T. Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med. 2008;162:914–xx. [PubMed] [Google Scholar]

43. Wendler D. Is it possible to protect pediatric research subjects without blocking appropriate research?. J Pediatr. 2008;152:467–470. [PMC free article] [PubMed] [Google Scholar]

44. Weijer C., Miller PB. Refuting the net risks test: a response to Wendler and Miller's “Assessing research risks systematically.”. J Med Ethics. 2007;33:487–490. [PMC free article] [PubMed] [Google Scholar]

45. Wendler D., Miller FG. Assessing research risks systematically: the net risks test. J Med Ethics. 2007;33:481–486. [PMC free article] [PubMed] [Google Scholar]

46. Dunn LB., Nowrangi MA., Palmer BW., Jeste DV., Saks ER. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry. 2006;163:1323–1334. [PubMed] [Google Scholar]

47. Okai D., Owen G., McGuire H., Singh S., Churchill R., Hotopf M. Mental capacity in psychiatric patients: systematic review. Br J Psychiatry. 2007;191:291–297. [PubMed] [Google Scholar]

48. Roberts LW., Warner TD., Nguyen KP., Geppert CM., Rogers MK., Roberts BB. Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation. Psychopharmacology (Berl). 2003;171:58–67. [PubMed] [Google Scholar]

49. Maclean A. . Autonomy Informed Consent and Medical Law. New York, NY: Cambridge University Press. 2009 [Google Scholar]

50. Editorial. Teaching responsible conduct of research. Lancet. 2009;374:1568. [PubMed] [Google Scholar]